GlassScriptPhysician profile
David K Harris
NPI 1710935093
$2,546.28
in general payments reported to CMS, 2019-2025
20 companies · $495 in 2025
The $495 reported for 2025 was more than what 77% of Spinal Cord Injury Medicine providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $173 · 2021: $519 · 2022: $475 · 2023: $405 · 2024: $221 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,121.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $949.97 | 2021-2025 | |
| Allergan, INC. | $588.28 | 2019-2022 | |
| Pacira Therapeutics, INC. | $204.27 | 2019-2021 | |
| Si-Bone, INC. | $186.05 | 2022-2025 | |
| Bioventus LLC | $101.95 | 2020-2025 | Xcell, Durolane |
| Smith+Nephew, INC. | $79.60 | 2023 | Na, Cap-Fix, Q-Fix |
| Collegium Pharmaceutical, INC. | $62.11 | 2025 | Belbuca, Xtampza |
| Horizon Therapeutics Plc | $55.14 | 2022 | |
| Stryker Corporation | $53.27 | 2022 | |
| Lumenis, INC | $47.09 | 2021 | |
| Pfizer INC. | $38.66 | 2023-2024 | |
| Teleflex LLC | $37.55 | 2021-2025 | Arrow |
| Depuy Synthes Sales INC. | $27.60 | 2025 | Orthovisc, Monovisc |
| Galderma Laboratories, L.P. | $24.15 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $18.48 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16.95 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $16.64 | 2019 | |
| Ibsa Pharma INC. | $13.76 | 2021 | |
| Scilex Pharmaceuticals INC. | $12.93 | 2020 | |
| Biodelivery Sciences International, INC. | $11.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.